Advertisement

“Sporadic” Colorectal Tumors in Multiple Primary Malignancies

  • Concetta Dodaro
  • Enrico Russo
  • Giuseppe Spinosa
  • Luigi Ricciardelli
  • Andrea Renda
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Strategic innovations in the fight against cancer have resulted in improved diagnosis of multiple primary malignancies (MPM). In fact, early detection has translated into an increased reported incidence of MPM, due to the spread of screening programs and to increasingly sophisticated instrumental diagnostic surveys. The high sensitivity and specificity of modern diagnostic technologies are such that second primary malignant neoplasms can be identified in their early stages, during follow-up for the first primary malignant tumor and even if the symptomatology is vague or the findings incidental. Also, the combined approach (with or without a neoadjuvant) to cancer therapy has yielded better long-term survival. In turn, compared to 30 years ago, more patients are being diagnosed with a second primary tumor [1-4].

Keywords

Colorectal Cancer Colorectal Carcinoma Lynch Syndrome Endometrial Carcinoma Colorectal Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moertel C (1977) Multiple primary malignant neoplasms. Cancer 40:1786–1792PubMedCrossRefGoogle Scholar
  2. 2.
    Parkin DM (2000) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543CrossRefGoogle Scholar
  3. 3.
    Dodaro C (1997) Colonic carcinoma associate to primari extracolic malignant tumors. Dig Surgery 10:105–106Google Scholar
  4. 4.
    Kan JY, Hsieh JS, Pan YS (2006) Clinical characteristics of patients with sporadic colorectal cancer and primary cancers of other organs. Kaoshing J Med Sci 22:547–553Google Scholar
  5. 5.
    Anonymous (2007) Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence — SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004) — Linked To County Attributes — Total US, 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submissionGoogle Scholar
  6. 6.
    Arnold MW, Young DM, Hitchcock CL et al (1998) Staging of colorectal cancer: biology vs. morphology. Dis Col Rect 41:1482–1487CrossRefGoogle Scholar
  7. 7.
    Renda A, Iovino F, Capasso L et al (1998) Radioimmunoguided surgery in colorectal cancer: a 6 years experience with four different technical solutions. Sem Surg Oncology 15:226–230CrossRefGoogle Scholar
  8. 8.
    Nastro P, Sodo M, Dodaro CA et al (2002) Intraoperative radiochromoguided mapping of sentinel lymph node in colon cancer. Tumori 88:352–353PubMedGoogle Scholar
  9. 9.
    Cangemi V (1990) I tumori maligni multipli primitivi. Chirurgia 3:461–4666Google Scholar
  10. 10.
    De Rosa M, Scarano MI, Panariello L et al (1999) Three submicroscopic deletions at the APC locus and their rapid detection by quantitative-PCR analysis. Eur J Hum Genet 7:695–703PubMedCrossRefGoogle Scholar
  11. 11.
    De Rosa M, Scarano MI, Panariello L et al (2003) The mutation spectrum of the APC gene in FAP patients from southern Italy: detection of known and four novel mutations. Hum Mutat 21:655–656PubMedCrossRefGoogle Scholar
  12. 12.
    Ueno M, Muto T, Oya M et al (2003) Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol 8:162–167PubMedCrossRefGoogle Scholar
  13. 13.
    Wang HZ, Huang XF, Wang Y et al (2004) Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma. World J Gastroenterol 10: 2136–2139PubMedGoogle Scholar
  14. 14.
    Chiang JM, Yeh CY, Changchien CR et al (2004) Clinical features of second other-site primary cancers among sporadic colorectal cancer patients — a hospital-based study of 3,722 cases. Hepatogastroenterology 51:1341–1344PubMedGoogle Scholar
  15. 15.
    Suspiro A, Fidalgo P, Cravo M et al (1998) The Muir-Torre Syndrome: a rare variant of Hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol 93:1572–1574PubMedCrossRefGoogle Scholar
  16. 16.
    Saegusa M, Hashimura M, Hara A, Okayasu I (1999) Loss of Expression of the gene deleted in colon carcinoma (DCC) is closey related to histologic differentiation and lymph node metastasis in endometrial carcinoma. Cancer 85:453–464PubMedCrossRefGoogle Scholar
  17. 17.
    Serleth HJ, Kisken WA (1998) A Muir-Torre syndrome family. Am Surg 64:365–369PubMedGoogle Scholar
  18. 18.
    Chen HS, Sheen Chen SM (2000) Synchronous and early metachronous colorectal adenocarcinoma. Dis Colon Rectum 43:1093–1099PubMedCrossRefGoogle Scholar
  19. 19.
    Derks S, Postma C, Carvalho B et al (2008) Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumor suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29:434–439PubMedCrossRefGoogle Scholar
  20. 20.
    Catasus L, Machin P, Matias-Guiu X, Prat J (1998) Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathology 29:1160–1165CrossRefGoogle Scholar
  21. 21.
    Neugut AI, Meadows AT, Robinson E (1999) Multiple primary cancer. Library of Congress Cataloging-in-Publication DataGoogle Scholar
  22. 22.
    Scaife CL, Rodriguez-Bigas MA (2003) Lynch syndrome: implications for the surgeon. Clin Colorectal Cancer 3:92–98PubMedCrossRefGoogle Scholar
  23. 23.
    Togashi K, Konishi F, Ozawa A et al (2000) Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43:S47–S53PubMedCrossRefGoogle Scholar
  24. 24.
    Chen HS, Sheen Cen SM (2000) Synchronous and early metachronous adenocarcinoma. Dis Colon Rectum 43:1093–1099PubMedCrossRefGoogle Scholar
  25. 25.
    Di Leo A, Linsalata M, Cavallini A et al (1992) Sex steroid hormone receptors, epidermal growth factor receptor and polyamines in human colorectal cancer. Dis Colon Rectum 35:305–309CrossRefGoogle Scholar
  26. 26.
    Heron DE, Komarnicky LT, Hyslop T et al (2000) Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88(12):2739–2750PubMedCrossRefGoogle Scholar
  27. 27.
    Promegger R, Ensinger C, Steiner P et al (2004) Neuroendocrine tumors and second primary malignancy-a relationship with clinical impact? Anticancer Res 24:1049–1051Google Scholar
  28. 28.
    Fukagai T, Ishihara M, Funabashi K et al (1996) Multiple primary malignant neoplasms associated with genitourinary cancer. Hinyokika Kiko 42:181–185Google Scholar
  29. 29.
    Hendrickse CW, Jones CE, Donovan IA et al (1993) Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 80:636–640PubMedCrossRefGoogle Scholar
  30. 30.
    Slattery ML, Samowitz WS, Holden JA (2000) Estrogen and progesterone receptors in colon tumors. Am J Clin Pathol 113:364–368PubMedCrossRefGoogle Scholar
  31. 31.
    Ribeiro G, Swindell R (1988) The Christie hospital adjuvant tamoxifen trial-status at 10 years. Br J Cancer. 57:601–603PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Concetta Dodaro
    • 1
  • Enrico Russo
    • 1
  • Giuseppe Spinosa
    • 1
  • Luigi Ricciardelli
    • 1
  • Andrea Renda
    • 1
  1. 1.Surgical, Anesthesiology-rianimative and Emergency Sciences DepartmentFederico II UniversityNaplesItaly

Personalised recommendations